Yale School of Public Health

Internationally Renowned Public Health Expert Sten Vermund Appointed President of the Global Virus Network (GVN)

Retrieved on: 
Thursday, November 2, 2023

BALTIMORE, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The Global Virus Network (GVN) today announced the appointment of Sten Vermund, MD, PhD , as President of the GVN.

Key Points: 
  • BALTIMORE, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The Global Virus Network (GVN) today announced the appointment of Sten Vermund, MD, PhD , as President of the GVN.
  • Lauder Professor of Public Health, former Dean of the Yale School of Public Health (2017-2022) and serves as a Professor in Pediatrics at the Yale School of Medicine.
  • Dr. Vermund transitions into his new role as Christian Bréchot, MD, PhD, ends his second term as GVN President, becoming Vice Chairman of the GVN Board of Directors.
  • Dr. Vermund became increasingly engaged in health policy, particularly related to sustainability of HIV/AIDS programs and their expansion to non-communicable diseases, the coronavirus pandemic response and prevention, and public health workforce development.

Top Virologists to Meet in Monaco to Tackle Ongoing Pandemic Challenges and Emerging Viral Threats

Retrieved on: 
Wednesday, October 11, 2023

This coalition of the world’s leading medical virology researchers, who work together to prevent illness and death from viral disease, will hold high-level scientific sessions examining pandemic preparedness and current threats.

Key Points: 
  • This coalition of the world’s leading medical virology researchers, who work together to prevent illness and death from viral disease, will hold high-level scientific sessions examining pandemic preparedness and current threats.
  • A special GVN-CSM joint session will focus specifically on preparedness in European Union countries and will be attended by the High Patronage of H.S.H.
  • Prince Albert II of Monaco, among other dignitaries.
  • Lander Professor of Public Health, Yale School of Public Health as its next GVN President, effective November 1, 2023.

Tevogen Bio Congratulates Innovation and Public Health Advisory Board Chairperson, Professor Sten Vermund on Being Elected to Serve as President of the Global Virus Network

Retrieved on: 
Thursday, October 12, 2023

Tevogen Bio Inc. (“Tevogen Bio”) congratulates Professor Sten Vermund, MD, PhD, Chairperson of Tevogen Bio’s Innovation and Public Health Advisory Board, on being elected to serve as the President of the Global Virus Network.

Key Points: 
  • Tevogen Bio Inc. (“Tevogen Bio”) congratulates Professor Sten Vermund, MD, PhD, Chairperson of Tevogen Bio’s Innovation and Public Health Advisory Board, on being elected to serve as the President of the Global Virus Network.
  • The Global Virus Network is a coalition comprised of leading virologists around the world, committed to solving viral diseases facing the human population.
  • The Board of Directors of the Global Virus Network (GVN) has elected Dr. Vermund to serve as President upon the close of the annual GVN scientific meeting being held October 19-21, 2023, in Monaco.
  • This new appointment complements his ongoing contributions at Tevogen Bio, where he continues to provide invaluable guidance on innovation and public health initiatives.

Spectral AI Adds Healthcare Services Leader and Population Health Expert Deepak Sadagopan to Board of Directors

Retrieved on: 
Monday, October 2, 2023

DALLAS, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of Deepak Sadagopan, MHCDS, to its board of directors.

Key Points: 
  • DALLAS, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of Deepak Sadagopan, MHCDS, to its board of directors.
  • Currently, Mr. Sadagopan is the Chief Operating Officer of Population Health at Providence St. Joseph Health, one of the largest healthcare systems in the U.S., where he leads population health initiatives across the system to transform care.
  • “Deepak brings a wealth of knowledge and relevant experience to Spectral AI as we advance the DeepView® System through late-stage development and launch,” said Wensheng Fan, the Company’s CEO.
  • Deepak’s contributions will enable us to continue to accelerate our work in bringing our technology to doctors and patients in need.

New survey shows Delta Dental patients rate their experiences with dentists a 9.5 out of 10

Retrieved on: 
Thursday, June 22, 2023

OAK BROOK, Ill., June 22, 2023 /PRNewswire/ -- Delta Dental announced key findings from the Consumer Assessment of Healthcare Providers and Systems (CAHPS®) Dental Plan Survey, which provides feedback from Delta Dental patients about their oral health care experiences.

Key Points: 
  • OAK BROOK, Ill., June 22, 2023 /PRNewswire/ -- Delta Dental announced key findings from the Consumer Assessment of Healthcare Providers and Systems (CAHPS®) Dental Plan Survey, which provides feedback from Delta Dental patients about their oral health care experiences.
  • Delta Dental is the only carrier utilizing the survey nationwide to continuously enhance patient experiences with its outstanding network of dentists.
  • Key results include:
    "The CAHPS Dental Plan Survey is an important tool for Delta Dental to advance our commitment to patient-centered care and provide excellent experiences for our members," said Joseph Dill, DDS, MBA, Chief Dental Officer, Delta Dental Plans Association.
  • "Delta Dental is the first and only dental carrier to deploy the CAHPS Dental Plan Survey with commercial groups on a national scale," added Dill.

Biotia Launches GeoSeeq Watchtower System: A Global Genomics-Based Infectious Disease Monitoring Program

Retrieved on: 
Friday, May 12, 2023

NEW YORK, May 12, 2023 /PRNewswire-PRWeb/ -- Biotia, a health tech company based in New York City, announced today its launch of the GeoSeeq Watchtower System. Using genomics, the program provides support for 12 groups monitoring infectious disease hotspots to profile emerging infectious disease risks.

Key Points: 
  • Deployed across eight countries on four continents, the program will generate genomics data to predict infectious disease threats and optimize outbreak response.
  • NEW YORK, May 12, 2023 /PRNewswire-PRWeb/ -- Biotia , a health tech company based in New York City, announced today its launch of the GeoSeeq Watchtower System.
  • Using genomics, the program provides support for 12 groups monitoring infectious disease hotspots to profile emerging infectious disease risks.
  • The COVID-19 pandemic highlighted the fragility of global health, social systems and economies and revealed the need for a more robust global infectious disease-monitoring system.

Miguel McInnis Appointed as President and CEO of Coordinated Transportation Solutions

Retrieved on: 
Wednesday, April 5, 2023

Coordinated Transportation Solutions (CTS) , a nationally recognized leader in non-emergent medical transportation (NEMT), has appointed Miguel McInnis as the company's new president and CEO effective March 31, 2023.

Key Points: 
  • Coordinated Transportation Solutions (CTS) , a nationally recognized leader in non-emergent medical transportation (NEMT), has appointed Miguel McInnis as the company's new president and CEO effective March 31, 2023.
  • He has succeeded David White, CTS’ founder, president and CEO, who retired after 25 years.
  • View the full release here: https://www.businesswire.com/news/home/20230405005312/en/
    Coordinated Transportation Solutions (CTS) has appointed Miguel McInnis as the new president and CEO effective March 31, 2023.
  • I look forward to working with CTS’ outstanding staff, board and community partners to build on its 25 years of connecting people with care,” said McInnis.

International Criminal Court has cited Russia's deportation of Ukrainian children a war crime: on Russia's long history of weaponising deportation

Retrieved on: 
Monday, April 3, 2023

On March 17, the International Criminal Court cited Russia’s deportation of Ukrainian children as a war crime for which President Vladimir Putin is being held responsible.

Key Points: 
  • On March 17, the International Criminal Court cited Russia’s deportation of Ukrainian children as a war crime for which President Vladimir Putin is being held responsible.
  • By some reports, since the invasion of Ukraine in February 2022, more than 6,000 children have been removed from Ukraine into Russia.
  • The UN Commission of Inquiry on Ukraine published evidence of the “illegal transfer of hundreds of Ukrainian children to Russia”.
  • A recent Yale School of Public Health report provides evidence of a organised attempt to reeducate abducted Ukrainian children now held in locations stretching from Russian-occupied Crimea to Siberia.
  • Centuries before the Russian invasion of Ukraine in February 2022, the expulsion of individuals or even entire nations was used as a targeted instrument of war.
  • He claimed the leadership not only of Moscow and its territories but of all lands of the ancient Kyivan Rus.
  • In 1767, Russian Ambassador Nicholas Repin ordered kidnapping and deportation to Kaluga of a group of Polish-Lithuanian parliamentarians who opposed Russian-sponsored legislation.
  • *
    Read more:
    Mount Kosciuszko: how Australia’s highest peak came to be named for a freedom fighter against Russian aggression
    *
    **

Ubiquitome gets FDA authorization with Yale SARS-CoV-2 self-collection tests

Retrieved on: 
Monday, December 19, 2022

Selected staff get trained on how to collect individual’s saliva samples and put them through the device systems in pooled batches.

Key Points: 
  • Selected staff get trained on how to collect individual’s saliva samples and put them through the device systems in pooled batches.
  • The results of the tests are delivered via proprietary software installed on any iPhone or iPad.
  • Dr Pickering says it is fantastic to see Ubiquitome’s name again listed by the FDA alongside some of the world’s biggest PCR manufacturers.
  • Only for diagnostic use for qualitative detection of nucleic acid from SARS-CoV-2 in saliva in laboratories designated by the Yale School of Public Health.

CMS’ Dr. Mary Greene To Keynote The Sequoia Project Annual Meeting

Retrieved on: 
Wednesday, December 7, 2022

Dr. Greene will address CMS’ interoperability priorities and burden reduction activities in her keynote presentation at 9 a.m. on Dec. 14 in Washington, DC.

Key Points: 
  • Dr. Greene will address CMS’ interoperability priorities and burden reduction activities in her keynote presentation at 9 a.m. on Dec. 14 in Washington, DC.
  • The keynote will complement other annual meeting speakers, including Mariann Yeager, CEO of The Sequoia Project, who will address the non-profit’s latest developments and upcoming priorities for 2023.
  • The Sequoia Project Annual Meeting runs from 7:30 a.m. to 5 p.m. Eastern time on Dec. 14.
  • The Sequoia Project is a non-profit, 501c3, public-private collaborative chartered to advance implementation of secure, interoperable nationwide health information exchange.